chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Heart Palpitations; Fatigue; Muscle aches; Headache; This is a spontaneous report from a contactable consumer, the patient.  A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration on 03Mar2021 at 10:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included stomach gastritis reportedly weeks after. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received penicillin and experienced allergy. On 03Mar2021 at 11:30, after 1-2 hours of vaccination, the patient experienced heart palpitations, muscle ache, fatigue and headache. On 03Mar2021 at 11:32, heart palpitations resolved after lasting for 2 minutes. On 04Mar2021, muscle ache, fatigue and headache resolved after lasting for one day. The patient called to report heart palpitations but this was considered normal yet patient felt there was no mention of this as a possible side effect. On 17Mar2021, post vaccination, the patient underwent oral swab test and the result was negative. The adverse events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. It was unknown whether the patient received treatment for the reported adverse events. The clinical outcome of the events heart palpitations resolved on 03Mar2021 at 11:32, muscle ache, fatigue  and headache were resolved on 04Mar2021. The patient had not received the second dose at the time of reporting.  No follow-up attempts are needed. No further information is expected.
I began to get unexplained headaches. I initially thought it was puberty however I've had hormones checked and entire neurological workups as an adult and medications are ineffective to relieve any pain.
I had itching on injection site immediately after shot. It wasn't terrible itching. But it was itching. I stayed at the pharmacy for 30 minutes before leaving. My main side effect was itching at injection site on arm. I continued to have itching on and off.  I didn't scratch it. I put Hydrocortisone cream on it, and tried also antibiotic cream, and Benadryl gel. I haven't had a lot of swelling. Just noticeable itching. Arm isn't swollen really. I didn't have a very sore arm either. It was mildly sore. Itching comes and goes still.
Fever; Body aches; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-May-2021 and was forwarded to Moderna on 02-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) and MYALGIA (Body aches) in a female patient of an unknown age who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch nos. 007C21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (unknown route) .5 milliliter. On 01-May-2021, received second dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) dosage was changed to 1 dosage form. On 02-May-2021, the patient experienced PYREXIA (Fever) and MYALGIA (Body aches). At the time of the report, PYREXIA (Fever) and MYALGIA (Body aches) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
5-7 mins after vaccination passed out and had shaking of arms and leg for few secs. Still having intermittent dizziness, headaches, low grade fever since then
Monday, 10/23/2017-- patient's mom called HD reporting that patient had received flu shot and started oral typhoid pills on Thursday 10/19/2017 and has not been feeling well since. He started with a low grade fever which spiked on Saturday to 103 F and a persistent cough, headache, and stomach upset (he has not had nausea or vomiting but has not really had an appetite). Patient has taken 2 oral typhoid pills, one on Thurs 10/19/17 and one on Sat 10/21/17, she was wondering if he should continue and take 3rd pill today. She states that patient does not have a fever today but still isn't feeling great. They are leaving on their trip on 11/17/2017 and will be there 8 days. I consulted with one other person and PaxVax Medical - they recommended that oral typhoid not be taken during acute febrile illness. Explained this to mom, told her that if patient is feeling better tomorrow he can take 3rd pill and finish oral typhoid series or if not recommended that he stop and start all over with oral typhoid or receive injectable typhoid when he is feeling better. Gave mom my direct phone number and she said she will call and let me know what they end up deciding.  10/26/2017--Called to f/u with mom, she states that patient has still not been feeling well and fever has persisted so he didn't take 3rd pill and mom is just waiting. I reiterated recommendation that he start oral typhoid series or receive injectable typhoid when he is feeling better so that he will have full protection for trip. Mom verbalized understanding and I asked if I could f/u with her next week, she told me 'no' I will call you. Decided to call mom back again to recommend that patient be seen by his primary doctor if he hasn't been since his symptoms haven't resolved, spoke to dad who states that mom is not available. Recommended to him that patient be seen by primary doctor if he hasn't been. He states that he does not think that they will have patient revaccinated with typhoid, I explained recommendation that he be revaccinated when he is feeling better to have the best protection for the trip. They will call back if they have any additional questions. 12/11/2017--As of today client/client's parents have not called or returned to HD to receive additional doses of oral typhoid pills or for client to receive injectable typhoid to ensure full protection.
Information has been received from a 64 year old female with no medical history and no drug allergies who on 29-JAN-2009 was vaccinated with a 0.65 ml dose of ZOSTER vaccine live (Oka/Merck) (lot # 662997/1619X).  Concomitant therapy included FLOVENT, vitamins (unspecified) and hormones (unspecified).  On 31-JAN-2009 the patient experienced swelling and redness after the vaccination.  The patient sought medical attention.  No lab tests performed.  As of 03-FEB-2009, the patient had not recovered.  Additional information is not expected.
Patient woke up feeling run down and exhausted that progressed throughout the day. Also felt nauseous, dizzy and woozy. Dissipated the next day. No treatment.
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were unknown. On 08-AUG-2016, the patient was vaccinated with one dose of ZOSTAVAX (dose and route of administration were not reported, lot # L003218) which expired on 30-APR-2016. Concomitant therapy was unknown. It was unknown if the lab diagnostics studies were performed. The patient's current status was unknown. Additional information has been requested.
My daughter had been battling migraines and joint pain and generalized fatigue for over three years. We started seeing a functional medicine specialist in April and radically altered her diet due to food sensitivities. Approximately two weeks prior to the Covid vaccine she had been free of migraines for over four weeks and free of generalized fatigue and joint pain for over two weeks. Within two hours of receiving the Covid vaccine her generalized fatigue and joint pain was back and has not yet resolved as of today.
5 days after vaccination I had partial vision impairment in my right eye.  I saw my eye doctor two days later who believed it was retinal vein occlusion.  He referred me to an ophthalmologist who I saw the following monday.  The ophthalmologist confirmed it was retinal vein occlusion.  His treatment was to administer an injection of medicine.
Patient reported light-headed and dizzy and collapsed in chair almost immediately following injection. EMS assessment and monitoring, recovered quickly. Reported numbness at injection site approximately 15min into monitoring which subsided before discharge. No treatment administered, patient was discharged from clinic completely recovered.
Adverse Event: The patient felt throat itching after 10 minutes of covid 19 vaccination ( 11:47 AM), thereafter the patient complaint throat closing. EMS was called @ ( 11:49 AM)  Treatment/Intervention: The patient was administered epinephrine 0.3ml on the right lateral thigh and EMS was also called (11:55 AM). The patient complained of itching and Benadryl 0.5ml was administered on the right deltoid.   Outcome: Throat constriction subsided and the patient only reported scratchy throat thereafter. EMS arrived on-site @ 12:10 pm and provided oxygen via nasal cannula  @ 15 L/ min and then transferred the  patient to a local hospital
I had vaccination on 05/21/2022 in my right thigh. I had back epidural on 05/19/2022. I had the second shingles shot on 06/10/2022. On 07/23/2022, we were exploring and hiking. I started to feel sick to my stomach. I checked my vitals and my blood pressure was 160/90 and the pulse was all over the place. I went to the emergency room and they put me on a heart monitor with EKGs. My heart stabilized back to normal rhythm. It was all over the place for about 12 hours and was very tiring. I was diagnosed with Atrial fibrillation. They put me on a beta blocker and a blood thinner metoprolol tartrate. Until I get home then I will follow up with my cardiologist.
really bad headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (really bad headache) and FATIGUE (fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Neosporin) and Drug allergy (codeine). Concomitant products included VITAMINS NOS for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (really bad headache) and FATIGUE (fatigue). At the time of the report, HEADACHE (really bad headache) and FATIGUE (fatigue) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not provided.  On 01-Apr-2021, patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) Intramuscularly into the left deltoid and reported she did not experience any side effects after the second dose.   This case was linked to MOD-2021-396118 (Patient Link).
feeling of tightness in her chest; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (feeling of tightness in her chest) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 027L20A) for COVID-19 vaccination.     Concurrent medical conditions included Atrial fibrillation. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (feeling of tightness in her chest). At the time of the report, CHEST DISCOMFORT (feeling of tightness in her chest) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: 50 (Low) below 50.         Treatment information was not provided by reporter.  Patient went to the emergency room where she stayed overnight due to the feeling of tightness in her chest and low heart rate below 50. Patient stated that she has developed bradycardia with heart rate of 45 to 50 pulse per minute after the first dose and still having episodes of it ever since.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-299694 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Not feeling ok; Arm was still a little sore; His wife had the second dose Saturday and reported soreness stronger than the first time and body ached a little bit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), for COVID-19 immunization, reaction(s): "Not feeling ok", "soreness stronger than the first time and body ached a little bit", "yesterday her arm was still a  little sore but today she is better". The following information was reported: PAIN (non-serious) with onset Apr2021, outcome "unknown", described as "His wife had the second dose Saturday and reported soreness stronger than the first time and body ached a little bit"; MALAISE (non-serious), outcome "unknown", described as "Not feeling ok"; PAIN IN EXTREMITY (non-serious), outcome "recovering", described as "Arm was still a little sore".  Additional Information: The reporter reported the event for his wife. Separate case created for the reporter and his mother. The reporter stated that his wife had the second dose on Saturday and reported soreness stronger than the first time and body ached a little bit, not feeling ok , nothing major, The reporter also stated that yesterday her arm was still a  little sore but today she is better.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received a COVID booster 1 week after getting a booster. She has a fever of 103
Patient was given dose that was higher than recommended dose due to error in measurement. Patient received approximately 0.6 to 0.65ml instead of 0.5ml dose.  Patient has not experienced adverse effects due to the increased dose at this time.
Excruciating arm pain injection site down to fingers, up to neck, around to scapula; pustule rash all over arm
Nausea; Headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration, in left arm on 16Mar2021 at 13:30 (at the age of 57-years-old) as single dose for COVID-19 immunisation. Patients medical history includes asthma, eosinophilic esophagitis, vitiligo, palpitations and anxiety. The patient was allergic to egg and milk. Concomitant medications included pravastatin (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN), LEXAPRO and ZETIA received for unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. It was unknown whether she was diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not tested positive for COVID-19. On 17Mar2021 at 07:00 the patient experienced nausea, headache and chills. The patient did not receive any treatment for the events. The clinical outcome of nausea, headache and chills were resolved.  No follow-up attempts are needed. No further information is expected.
This spontaneous prospective pregnancy report as received from a medical assistant refers to a female patient of unknown age. There was no information about patient's concomitant medications and pertinent medical history reported. On an unknown dates, the patient was vaccinated with GARDASIL 9 dose 1 and dose 2, (dose, route, anatomical location, lot numbers and expiration dates were not provided) for prophylaxis. The patient was in the office to receive her 3rd dose, but informed that she was currently 11 weeks pregnant. The patient became pregnant with Last Menstrual Period of 03-MAY-2016 and Estimated Delivery Date of 07-FEB-2017. The medical assistant stated that the patient did not receive a vaccine during pregnancy. No other suspect medications or concomitant therapies were reported. No product quality complaint was involved. At the time of the report, the outcome of the event was unknown. Additional information has been requested. Sender's Comments: MERCK 1607USA007927: Mfr number.
After my vaccine and two days later I started to experience migraine headaches which I never suffered from before.  I went to Quick care facility to seek treatment. To this day, I still have the migraine headaches and I can not function well and carry out my daily activities.
Presented 1/16 with left facial weakness, which progressed to left sided weakness, followed by altered mental status and intubation for severe encephalopathy. MRI brain with bilateral white matter changes consistent with either watershed infarcts versus leukoencephalopathy. He remains comatose and intubated with severe spasticity.
Hives; allergy reaction; This case was reported by a consumer and described the occurrence of hives in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced hives and allergic reaction. On an unknown date, the outcome of the hives and allergic reaction were unknown.   It was unknown if the reporter considered the hives and allergic reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and experienced hives. The reporter asked what are the components that can asked doctor to did allergy testing on. The patient was concerned about potential increased reactions of a second dose.
I received 2nd dose of vaccine on Jan 11.   On the date above I developed eye irritation.   The next day I couldn?t blink that eye and was diagnosed with Bells Palsy.
This spontaneous report was received from a Certified Medical Assistant referring to unspecified patients. Patients' medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored VAQTA lot # L023232 and expiry date 25-FEB-2017 (strength, dose, frequency and route were not reported). Concomitant medications were not provided. No adverse effects were reported and no product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Pt vaccinated with Meruvax developed arthralgia which persisted for 6-8wks. Developed fever & macular papular rash, swelling of the joints.
Fever Chills Terrible muscle and joint pain that Tylenol did not help with Headache that Tylenol did not help with Mouth sores Tired  Still feels sick 4 days after the shot
Severe muscle pain in torso and shooting pains in back of thighs lasting a week, vertigo lasting 2 days, and could not raise left arm over my head which lasted a week - with rest and exercise I have better movement of my arm however it has been over a month and my arm is still sore even with Tylenol
After the initial chills, headache and diarrhea, the third day my back and arms were burning within. It would come and go and as the days went on the sensation would last longer and more frequent. The sensation went away after approximately 12 days from initial onset, and 14 days from the day of the vaccination.
12AUG95 devel mild h/a, fever to 102 & myalgias; seen in clinic 14AUG feeling better, t98.9, unremarkable exam; one erythematous papule (asymptomatic); pt feeling better on 14AUG
4 days after vaccine right top of foot swollen/painful. Next day in AM - pain entire right leg and into body. Marked pain and weakness - muscle spasms - could not get out of bed. Went to ED. Lab work (increase sed rate). Diagnosis - severe serum sickness reaction (steroids, pain Rx)
No Adverse effects reported; improperly stored dose of PEDVAX HIB was administered to the patient; This spontaneous report was received from a medical assistant referring to a patient of unknown age and unknown gender. Information about pertinent medical history, drug reactions/allergies and concomitant medication was not reported.  On 19-JUN-2019, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot # R027328 with expiration date 12-JUL-2021 (dose detail and route were not reported) for prophylaxis.  The vaccine experienced improperly stored and was stored above 47 Fahrenheit degrees/ 9 degree Celsius (47.4 Fahrenheit degrees) for 1 hour and 30 minutes. There was no previous temperature excursion and the call was because of a data logger involved. No adverse effects were reported.
Moderate chills, muscle aches, joint pain beginning about 12 hours following the second dose of Pfizer vaccine.  Moderate pain at the injection site beginning about 6 hours following the second dose.
I was at a conference and the staff called for help and rushed me to the ER, my blood pressure was extremely elevated and at stroke levels.  The levels of carbamazepine were very elevated.  I think the vaccine elevated the levels of the medicine in my system.
Due to equipment failure (syringe), while injecting, the entire dose ran down her arm. Per protocol, another full dose was administered.
Symptom 1: Pain and tenderness in the same arm of injection; time course: 24-36 hours; treatment: acetaminophen, hot/cold compresses, rest; outcome: symptoms subsided.  Symptoms 2-7: Dizziness, numbness/weakness all over the body (beginning at lower extremities, radiating upwards), headache, fatigue, muscle/joint pain, fever; treatment: food, water, acetaminophen, hot/cold compresses, rest; time course/outcome: dizziness, numbness/weakness (2 days, dissipated), headaches (1-2x/daily for 4 days, worse at the beginning; better as time progressed), muscle/joint pain (same duration, pain level, and outcome as headaches), fatigue/fever (3 days, then improved/dissipated).
Patient suddenly felt hot, sweaty, nauseous, was lightheaded. Was coughing a lot. Rested in cool place, then felt better. Was seen to have tremor at that time, but not witnessed on exam. Improved within about 2 hours. Vaccine sites normal. Suspected diagnosis: FB aspiration (phlegm), cleared.